Swanson C et al. |
FK 506-based immunosuppression in clinical pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539827
|
Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Klintmalm GB and Gonwa TA |
Nephrotoxicity associated with cyclosporine and FK506. |
1995 |
Liver Transpl Surg |
pmid:9346596
|
Wong PY et al. |
FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. |
1995 |
Liver Transpl Surg |
pmid:9346613
|
Todo S et al. |
Abdominal multivisceral transplantation. |
1995 |
Transplantation |
pmid:7530873
|
Fukuzaki T et al. |
A protocol with FK 506 for inducing unresponsiveness to murine islet allografts. |
1995 |
Surgery |
pmid:7531371
|
Jain AB et al. |
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. |
1995 |
Transplant. Proc. |
pmid:7533353
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Schwartz M et al. |
FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization. |
1995 |
Transplant. Proc. |
pmid:7533355
|
Yasuhara M et al. |
Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. |
1995 |
Transplant. Proc. |
pmid:7533356
|
Platz KP et al. |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. |
1995 |
Transplant. Proc. |
pmid:7533357
|
Bierer BE |
Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin. |
1995 |
Proc. Assoc. Am. Physicians |
pmid:8630742
|
Chakraborty TK et al. |
Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand. |
1995 |
Chem. Biol. |
pmid:9383417
|
Kuroki H and Ikuta Y |
Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survivals treated by short course of FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533405
|
Ko S et al. |
Significance of newly developed liposomal FK 506 in canine liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7533406
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. |
1995 |
Transplant. Proc. |
pmid:7533407
|
Grochowicz PM et al. |
Synergism of castanospermine and FK 506. |
1995 |
Transplant. Proc. |
pmid:7533408
|
Itoh S and Navia MA |
Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). |
1995 |
Protein Sci. |
pmid:8563622
|
Tamura K et al. |
Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high. |
1995 |
Transplant. Proc. |
pmid:7533409
|
Kawano K et al. |
Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. |
1995 |
Transplant. Proc. |
pmid:7533410
|
Charters AR et al. |
Developmental expression of FK506 binding proteins and calcineurin in rat brain. |
1995 |
Biochem. Soc. Trans. |
pmid:8566310
|
Sen J et al. |
Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. |
1995 |
J. Immunol. |
pmid:7534792
|
Hodgkiss JP and Kelly JS |
Only 'de novo' long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex. |
1995 |
Brain Res. |
pmid:8821755
|
Komori T |
[The change of lymphocyte subset and effect of FK506 in experimental small bowel transplantation of rats]. |
1995 |
Nihon Geka Gakkai Zasshi |
pmid:7534867
|
Woo J et al. |
Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice. |
1995 |
Clin. Exp. Immunol. |
pmid:7535208
|
Jusko WJ et al. |
Pharmacokinetics of tacrolimus in liver transplant patients. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7535213
|
Winkler M and Christians U |
A risk-benefit assessment of tacrolimus in transplantation. |
1995 |
Drug Saf |
pmid:7545405
|
Nowaczyk M et al. |
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). |
1995 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:8744655
|
Ockenfels HM et al. |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. |
1995 |
Arch. Dermatol. Res. |
pmid:7541191
|
Victor RG et al. |
Presynaptic modulation of cortical synaptic activity by calcineurin. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7541535
|
Mehta BA et al. |
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. |
1995 |
Blood |
pmid:7579455
|
Hemenway C |
FK506 in bone marrow transplantation. |
1995 |
Blood |
pmid:7579473
|
Yamamoto M et al. |
Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. |
1995 |
Anticancer Drugs |
pmid:7579561
|
Zhao Y and Iwata M |
Cross-linking of the TCR-CD3 complex with CD4, CD8 or LFA-1 induces an anti-apoptotic signal in thymocytes: the signal is canceled by FK506. |
1995 |
Int. Immunol. |
pmid:7495746
|
O'Gorman MA et al. |
Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients. |
1995 |
Clin Transplant |
pmid:7579739
|
Aono T et al. |
Minimal threshold of FK 506 for enhancing liver regeneration in thymectomized rats. |
1995 |
Transplant. Proc. |
pmid:7536981
|
Saito T et al. |
In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. |
1995 |
FEBS Lett. |
pmid:7498550
|
Kanamaru A et al. |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. |
1995 |
Bone Marrow Transplant. |
pmid:7581086
|
Iwabuchi T et al. |
Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth. |
1995 |
J. Dermatol. Sci. |
pmid:7537082
|
Antoni FA et al. |
Calcineurin feedback inhibition of agonist-evoked cAMP formation. |
1995 |
J. Biol. Chem. |
pmid:7499291
|
Arnold JC and Theilmann L |
[Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. |
1995 |
Z Gastroenterol |
pmid:7502559
|
Osman A et al. |
Schistosoma mansoni: characterization of p50, an immunophilin. |
1995 |
Exp. Parasitol. |
pmid:7537219
|
Tanida I et al. |
Cooperation of calcineurin and vacuolar H(+)-ATPase in intracellular Ca2+ homeostasis of yeast cells. |
1995 |
J. Biol. Chem. |
pmid:7537264
|
Prud'homme GJ et al. |
Effects of cyclosporin A, rapamycin, and FK520 on peripheral T-cell deletion and anergy. |
1995 |
Cell. Immunol. |
pmid:7543371
|
Migita K et al. |
FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. |
1995 |
J. Clin. Invest. |
pmid:7543492
|
Lhoëst G et al. |
The in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7543569
|
Textor SC et al. |
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. |
1995 |
Kidney Int. |
pmid:7543625
|
Ko S et al. |
The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. |
1995 |
Transplantation |
pmid:7539553
|
Dollinger MM et al. |
Tacrolimus and cardiotoxicity in adult liver transplant recipients. |
1995 |
Lancet |
pmid:7543645
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Romero DF et al. |
Rapamycin: a bone sparing immunosuppressant? |
1995 |
J. Bone Miner. Res. |
pmid:7543725
|
Hisatomi K et al. |
Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection. |
1995 |
Surg. Today |
pmid:7539647
|
Taler SJ et al. |
Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. |
1995 |
Am. J. Hypertens. |
pmid:7544983
|
Teague S |
Lessons from molecular matchmakers. |
1995 |
Nat. Struct. Biol. |
pmid:7545076
|
Ito T et al. |
Immunosuppressive agents induce the reduction of local pancreatic blood flow. |
1995 |
Pancreas |
pmid:7545292
|
Zhang J and Steiner JP |
Nitric oxide synthase, immunophilins and poly(ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. |
1995 |
Neurol. Res. |
pmid:7477744
|
Han CW et al. |
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. |
1995 |
Bone Marrow Transplant. |
pmid:7545487
|
Jindal RM and Popescu I |
Renal dysfunction associated with liver transplantation. |
1995 |
Postgrad Med J |
pmid:7479462
|
Yeh WC et al. |
Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479941
|
Yeh WC et al. |
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479942
|
Shaw KT et al. |
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479966
|
Groth CG |
Immunosuppressive regimens of tomorrow. |
1995 |
Transplant. Proc. |
pmid:8539797
|
Hariharan S et al. |
Conversion from cyclosporine to tacrolimus after pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539799
|
Henley SE et al. |
Lipids following pancreas transplantation in recipients receiving FK 506. |
1995 |
Transplant. Proc. |
pmid:8539809
|
Stratta RJ et al. |
Preliminary experience with FK 506 in pancreas transplant recipients. |
1995 |
Transplant. Proc. |
pmid:8539823
|
DÃaz M et al. |
[Tacrolimus (FK 506): an immunosuppression alternative in solid organ transplantation. (Part 2)]. |
1995 Apr-Jun |
Rev Med Univ Navarra |
pmid:7569553
|
Hisatomi K et al. |
Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats. |
1995 Jan-Feb |
J. Heart Lung Transplant. |
pmid:7537098
|
DÃaz M et al. |
[Tacrolimus (FK 506): immunosuppressive alternative to solid organ transplant (Part 1)]. |
1995 Jan-Mar |
Rev Med Univ Navarra |
pmid:14735715
|
Kawahara K et al. |
Effects of deoxyspergualin on bronchial anastomosis healing in canine pulmonary allografts. |
1995 Jul-Aug |
J. Heart Lung Transplant. |
pmid:7578196
|
Motoyama K et al. |
Pretransplant intrathymic inoculation of donor antigen combined with FK506 treatment: prolongation of survival of cardiac, but not renal, allografts in rats. |
1995 Mar-Apr |
World J Surg |
pmid:7538717
|
Okudaira H et al. |
Enhanced production and gene expression of interleukin-5 in patients with bronchial asthma: possible management of atopic diseases by down-regulation of interleukin-5 gene transcription. |
1995 May-Jun |
Int. Arch. Allergy Immunol. |
pmid:7542077
|
Su Q et al. |
Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphatase. |
1995 May-Jun |
Ren. Physiol. Biochem. |
pmid:7542793
|
Hayashi S et al. |
Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation. |
1995 May-Jun |
J. Heart Lung Transplant. |
pmid:7544621
|
Castillo Lugo JA |
Clinical and experimental immunosuppression. |
1995 May-Jun |
Bol Asoc Med P R |
pmid:8573248
|
Seifeldin R |
Drug interactions in transplantation. |
1995 Nov-Dec |
Clin Ther |
pmid:8750397
|
Schreiber SL and Crabtree GR |
Immunophilins, ligands, and the control of signal transduction. |
1995-1996 |
Harvey Lect. |
pmid:9127988
|
Igarashi O et al. |
B7-1 synergizes with interleukin-12 in interleukin-2 receptor alpha expression by mouse T helper 1 clones. |
1996 |
Eur. J. Immunol. |
pmid:8617295
|
Rappersberger K et al. |
Clearing of psoriasis by a novel immunosuppressive macrolide. |
1996 |
J. Invest. Dermatol. |
pmid:8618008
|
Andereggen E et al. |
Immunohistological study of islet xenograft rejection in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623420
|
Kinoshita I et al. |
Myoblast transplantation in monkeys: control of immune response by FK506. |
1996 |
J. Neuropathol. Exp. Neurol. |
pmid:8642394
|
Singh N et al. |
Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. |
1996 |
Surgery |
pmid:8644012
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Velio P et al. |
Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506. |
1996 |
Transplant. Proc. |
pmid:8907936
|
Licitra EJ and Liu JO |
A three-hybrid system for detecting small ligand-protein receptor interactions. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8917502
|
Woodle ES et al. |
Treatment of acute glomerular rejection with FK 506. |
1996 |
Clin Transplant |
pmid:8826664
|
Platz KP et al. |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. |
1996 |
Transplant. Proc. |
pmid:8962235
|
Mollison KW et al. |
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the rat. |
1996 |
Transplant. Proc. |
pmid:8962236
|
Johnson MW et al. |
Hepatitis C viral infection in liver transplantation. |
1996 |
Arch Surg |
pmid:8611094
|
Chen BG et al. |
Inhibition by CsA and FK506 of the in vitro proliferative response of gamma delta T cells on stimulation with anti-TCR delta monoclonal antibody. |
1996 |
Transpl. Immunol. |
pmid:8843593
|
Andrews PA et al. |
Racial variation in dosage requirements of tacrolimus. |
1996 |
Lancet |
pmid:8937292
|
Toyota N et al. |
Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. |
1996 |
Arch. Dermatol. Res. |
pmid:8844128
|
Hohage H et al. |
Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients. |
1996 |
Clin. Nephrol. |
pmid:8738668
|
Herget S et al. |
Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection. |
1996 |
Clin. Nephrol. |
pmid:8738671
|
Dawson S et al. |
UCLA liver transplantation: analysis of immunological factors affecting outcome. |
1996 |
Artif Organs |
pmid:8896726
|
Bell A et al. |
The antiparasite effects of cyclosporin A: possible drug targets and clinical applications. |
1996 |
Gen. Pharmacol. |
pmid:8909976
|
Kashu Y et al. |
Prolongation of rat liver graft survival by splenectomy combined with low dose FK506 therapy. |
1996 |
Artif Organs |
pmid:8896731
|
Weigao C |
[Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)]. |
1996 |
Fukuoka Igaku Zasshi |
pmid:8913057
|
Tsugita M et al. |
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. |
1996 |
Transplantation |
pmid:8685952
|
Huntress JD and Papadakos PJ |
The role of calcium-channel antagonists in solid organ transplantation. |
1996 |
New Horiz |
pmid:8689268
|
|
[Transplantation medicine. Tacrolimus increases survival chances after organ transplantation. XVI International Congress of the Transplantation Society. 25-30 August 1996 Barcelona]. |
1996 |
Dtsch. Med. Wochenschr. |
pmid:9447224
|